153 related articles for article (PubMed ID: 35048)
1. [Vitamin K antagonists].
Chabalier R; Lévy G
Ann Anesthesiol Fr; 1978; 19(10):IN-5N. PubMed ID: 35048
[No Abstract] [Full Text] [Related]
2. [In practice: use of vitamin K antagonists].
Heidinger K
Pharm Unserer Zeit; 2004; 33(3):236-43. PubMed ID: 15208912
[No Abstract] [Full Text] [Related]
3. [Anticoagulants (heparin, antivitamins K, principles and rules of use)].
Lecompte T; Horellou MH
Rev Prat; 1992 May; 42(10):1280-8. PubMed ID: 1609224
[No Abstract] [Full Text] [Related]
4. New anticoagulants: an update.
Crowther M; Weitz JI
Clin Adv Hematol Oncol; 2004 Nov; 2(11):743-9. PubMed ID: 16170892
[TBL] [Abstract][Full Text] [Related]
5. [Control of long-term therapy with antivitamins K].
Mascart P; Cloetens W
Angeiologie; 1967; 19(5):45-8. PubMed ID: 5621972
[No Abstract] [Full Text] [Related]
6. [Conditions of resistance to vitamin K antagonists].
Marchal G; Samama M; Charon P
Sem Ther; 1964 Dec; 40(10):623-7. PubMed ID: 5878936
[No Abstract] [Full Text] [Related]
7. [Vitamin K antagonists].
D'Agostino F; D'Agostino M; Cambiè G; Cuccia A
Riv Emoter Immunoematol; 1983; 30(1):1-31. PubMed ID: 6635478
[No Abstract] [Full Text] [Related]
8. [Biologic control of long-term anti-coagulating therapy with antivitamins K].
Samama M; Casubolo L
Angeiologie; 1967; 19(5):37-43. PubMed ID: 5621971
[No Abstract] [Full Text] [Related]
9. [Antivitamin K. Introduction].
Larcan A
Angeiologie; 1967; 19(5):33-5. PubMed ID: 5621970
[No Abstract] [Full Text] [Related]
10. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
Raby C
Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
[No Abstract] [Full Text] [Related]
11. [Anticoagulant therapy with antivitamins K].
Bokarev IN; Kabaeva EV
Klin Med (Mosk); 1984 Jan; 62(1):18-24. PubMed ID: 6708415
[No Abstract] [Full Text] [Related]
12. Determinants of the response to oral anticoagulant drugs in man.
O'Reilly RA; Aggeler PM
Pharmacol Rev; 1970 Mar; 22(1):35-96. PubMed ID: 4918964
[No Abstract] [Full Text] [Related]
13. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
Delsart D; Chambefort V; Decousus H
Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
[No Abstract] [Full Text] [Related]
14. [Antivitamin K agents].
Nicolas G
Rev Prat; 1973 Dec; 23(60):5393-400. PubMed ID: 4794218
[No Abstract] [Full Text] [Related]
15. [Principles, limits, and modalities of application of classical anticoagulants].
Vergoz D
Phlebologie; 1973; 26(1):105-7. PubMed ID: 4724444
[No Abstract] [Full Text] [Related]
16. Anticoagulation control with vitamin K antagonists: how well are we doing?
Lane DA; Boos CJ; Lip GY
Chest; 2006 May; 129(5):1122-4. PubMed ID: 16684999
[No Abstract] [Full Text] [Related]
17. [Biochemical basis for the control of anticoagulant and thrombolytic therapy].
Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):116-28. PubMed ID: 4098766
[No Abstract] [Full Text] [Related]
18. The challenge of regulating anticoagulant drugs: focus on warfarin.
Mann KG
Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
[No Abstract] [Full Text] [Related]
19. Novel oral anticoagulants and diet: the potential for interaction.
Kamali F
Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
[No Abstract] [Full Text] [Related]
20. [Mechanisms of action of oral anticoagulants].
Uszyński L
Acta Haematol Pol; 1972; 3(2):133-9. PubMed ID: 4655612
[No Abstract] [Full Text] [Related]
[Next] [New Search]
